Free Trial

Jamieson Wellness (TSE:JWEL) Stock Price Up 0.1% - Time to Buy?

Jamieson Wellness logo with Consumer Defensive background
Image from MarketBeat Media, LLC.

Key Points

  • Analyst upgrades: Several brokerages raised targets (National Bank to C$45, TD to C$48, CIBC to C$43), leaving a MarketBeat consensus rating of Buy with an average target of C$44.
  • Recent results and leverage: Last quarter EPS was C$0.90 on C$277.7M revenue with ROE 12.97% and net margin 7.6%, while the company carries a high debt-to-equity ratio of ~97.2% and moderate liquidity (current ratio 2.59, quick ratio 1.08).
  • Dividend and valuation: Jamieson pays a C$0.23 quarterly dividend (C$0.92 annualized) for a ~2.7% yield, with a PE of ~23 and a market cap of ~C$1.4B.
  • MarketBeat previews top five stocks to own in June.

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) shares shot up 0.1% during trading on Tuesday . The company traded as high as C$33.98 and last traded at C$33.65. 111,868 shares changed hands during mid-day trading, an increase of 31% from the average session volume of 85,245 shares. The stock had previously closed at C$33.62.

Analyst Ratings Changes

A number of brokerages have commented on JWEL. National Bank Financial upped their price target on Jamieson Wellness from C$40.50 to C$45.00 and gave the stock an "outperform" rating in a research report on Monday, February 23rd. TD Securities upped their price target on Jamieson Wellness from C$46.00 to C$48.00 and gave the stock a "buy" rating in a research report on Monday, March 2nd. Finally, Canadian Imperial Bank of Commerce set a C$43.00 price target on Jamieson Wellness and gave the stock an "outperform" rating in a research report on Tuesday, March 24th. Four analysts have rated the stock with a Buy rating, According to MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of C$44.00.

Read Our Latest Research Report on Jamieson Wellness

Jamieson Wellness Stock Performance

The company has a debt-to-equity ratio of 97.24, a current ratio of 2.59 and a quick ratio of 1.08. The business has a 50-day simple moving average of C$34.86 and a 200 day simple moving average of C$34.76. The firm has a market cap of C$1.40 billion, a PE ratio of 23.05 and a beta of 1.46.

Jamieson Wellness (TSE:JWEL - Get Free Report) last released its earnings results on Thursday, February 26th. The company reported C$0.90 earnings per share (EPS) for the quarter. Jamieson Wellness had a return on equity of 12.97% and a net margin of 7.60%.The firm had revenue of C$277.66 million during the quarter. Equities research analysts forecast that Jamieson Wellness Inc. will post 2.1438892 EPS for the current year.

Jamieson Wellness Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 16th were given a dividend of $0.23 per share. The ex-dividend date was Friday, March 6th. This represents a $0.92 annualized dividend and a dividend yield of 2.7%. Jamieson Wellness's dividend payout ratio (DPR) is currently 60.27%.

About Jamieson Wellness

(Get Free Report)

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Jamieson Wellness Right Now?

Before you consider Jamieson Wellness, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.

While Jamieson Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines